GM

Gaurav Mangol

Active Director Director DIN 08217347
DIN 08217347 First appointment Sep 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Gaurav Mangol

Data last updated:

Gaurav Mangol is a Director at Sonoscape Medical India Private Limited (since 2018). The company operates in Healthcare. Sonoscape Medical India Private Limited reported revenue of ₹39.66 Cr (FY 2024).

DIN 08217347
Primary Designation Director
Industry Healthcare
First Appointment 06 Sep 2018
Oldest Company Age 8 yrs
Largest company Sonoscape Medical India Private Limited · ₹39.66 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Sep 20182018₹39.66 Cr (FY 2024)Active

Board colleagues of Gaurav Mangol

Directorship timeline

Open interactive timeline →
Sonoscape Medical India Private Limited
Premium access

Shareholding and investment profile for Gaurav Mangol

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Mangol

Gaurav Mangol currently holds 1 directorship: Sonoscape Medical India Private Limited (Director, since 06 Sep 2018, revenue ₹39.66 Cr (FY 2024)).

Gaurav Mangol was first appointed on 06 Sep 2018 as Director at Sonoscape Medical India Private Limited.

The current boards of Gaurav Mangol's companies include Hui Rang (Sonoscape Medical India Private Limited), Navaneethakrishnan Kalaiselvan (Sonoscape Medical India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available